Issues for Purchasing Contracts and Quality Agreements in the Generic Pharma Industry Tuesday, March 11, 2008 Waldorf-Astoria Hotel, New York 8:30 am-10:00 am Empire Room
Registration for this program is now closed.  Walk-in attendees are welcome the day of the program. Only credit card payments will be accepted on site.”
The cancellation deadline for this program was Monday, March 3rd at 12:00pm EST.  In order to receive a full refund, you must have submitted your cancellation request prior to that date.

Education Program Sponsor: 

Program Hospitality Sponsors:

As supply chains in the generic pharmaceutical industry become increasingly global and more complex, internal control over the procurement process has become more challenging.  This program will offer participants insight on two contract-related subjects of interest to generic pharmaceutical companies trying to better control this phase of their business. 1) The legal risks inherent in purchase order contracting.  Most procurement transactions entered into by generic pharmaceutical companies are transacted without separate commercial supply agreements signed by both parties. 2) The trend towards quality agreements.  U.S. generic pharmaceutical manufacturers are increasing their efforts to require quality agreements from API suppliers.  This program will cover how these agreements, if properly managed, can help both suppliers and manufacturers control their supply chains.  The speakers will discuss these subjects from different vantage points to provide participants with an excellent overview of these important issues.

This program was developed by the DCAT Generic Pharma Council.

Program Fees: Member Company - $89.00, Non-Member Company - $259.00. 

About the Speakers:

Stephen D. Sayre, Esq., is an attorney with Dykema law firm, Chicago, IL. His practice includes corporate lending and finance transactions including asset-based loans, cash-flow loans, construction loans, and multibank syndicated loan facilities (representing agents as well as participants).  Mr. Sayre's practice also includes mergers and acquisitions, general corporate and commercial contracting matters, with particular emphasis on international commercial agreements for pharmaceutical companies and information technology contracts. He has co-authored two articles with Mr. Gattoni, in August of 2007 the Journal of Generic Medicines,  "Attention API Suppliers: Quality Agreements Are Here To Stay,"  and in the September 2007 issue of Pharmaceutical Technology,  "The Perils of Purchase-Order Contracting In Pharmaceutical Transactions."

Mr. Sayre began his legal career as a law clerk to the Honorable Mary L. Cooper, United States District Court Judge for the District of New Jersey. Prior to law school, Mr. Sayre worked as a Certified Public Accountant for Ernst & Whinney and in private industry in the areas of auditing and accounting.

Todd Grant Gattoni, Esq., is an attorney with Dykema law firm, Chicago, IL. His practice focuses on complex civil litigation with an emphasis on products liability, business and environmental/toxic tort claims. A significant portion of his products liability practice involves defending mass tort and class action lawsuits against pharmaceutical and medical device manufacturers, including electrical surgical devices, prosthetic heart valves, and pacemakers.  This section of his practice also includes providing product liability and risk management counseling to manufacturers and distributors of industrial and retail products, including review of product labeling and warnings. He has co-authored two articles with Mr. Sayre, in August of 2007 the Journal of Generic Medicines,  "Attention API Suppliers: Quality Agreements Are Here To Stay," and in the September 2007 issue of Pharmaceutical Technology,  "The Perils of Purchase-Order Contracting In Pharmaceutical Transactions."

Prior to joining Dykema, Mr. Gattoni was a partner with Reed Smith LLP in Oakland, California.  In 2004 he was recognized as one of California's "Super Lawyers".